Clinical trial

Assessing Inherited Markers of Metabolic Syndrome in the Young

NCT00966407

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

Assessing Inherited Markers of Metabolic Syndrome in the Young

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-02-01

PhaseN/A

Conditions

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Obesityverified · MONDO: obesity disorder

Interventions

Sponsors & collaborators

Eric Hoffmanlead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)collaborator

Howard Universitycollaborator

University of Massachusetts, Worcestercollaborator

East Carolina Universitycollaborator

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00966407 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.